5/26/2017 Contest update
Generic comments about high drug prices by new FDA commissioner, Scott Gottlieb, may have scared off biotech investors, with biotech stocks underperforming the broad market for the week.
At Friday’s close, the Contest median was up 11.45% YTD (vs. up 15.75% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 8.81% YTD (vs. up 9.62% YTD a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 16.07% YTD (vs. up 16.67% YTD a week ago). The Nasdaq Composite Index (NCI) closed up 15.36% YTD (vs. up 13.01% YTD a week ago).
TOMP’s portfolio, up 55.14% YTD, held on to the Contest lead, but HRS’s portfolio, up 53.21% YTD, jumped into second place with a lift from a 20% allocation to PIRS and is close behind. ROBO’s portfolio, up 48.06% YTD, slipped to third place.
At Friday's close, 42 of the 48 Contest portfolios were in the green, with 31 beating the NBI and 19 beating the SPSIBI.
The 195 Contest portfolio stock picks have an average YTD gain of 11.05% and a median YTD gain of just 1.94%, with 99 of the 195 picks up for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None
(All corrections, especially adjustments for splits, greatly appreciated.)
Enjoy a safe & fun Memorial Day weekend biotechies!
Peace & good health,
Bulba
5/26/17
Rank Name Profit/Loss
1 TOMP 55,135
2 HRS 53,211
3 ROBO 48,056
4 BIOADD 43,014
5 SMALLB 31,379
6 TUCK 30,002
7 YVR 28,928
8 NIGEL 25,332
9 JFM 25,319
10 KMASTR 24,746
Week's Top 5 Gainers
Symbol 5/19/17 5/26/17 Wk.%chg.
MEIP 1.62 2.12 30.86%
NWBO 0.16 0.18 12.90%
PMN.TO 0.29 0.33 12.07%
CFRX 1.25 1.40 12.00%
ZSAN 1.34 1.49 11.19%
Week's Worst 5 Losers
Symbol 5/19/17 5/26/17 Wk.%chg.
ARDX 6.08 4.60 -24.28%
TRIL 5.95 5.00 -15.97%
LJPC 34.000 29.020 -14.65%
ALXN 113.84 97.70 -14.18%
SRPT 34.64 30.01 -13.37%
|
